Gene and Cell Therapy Institute

Team

The Gene and Cell Therapy Institute's leadership actively fosters and establishes both internal and external connections to drive forward the advancement of gene and cell therapy treatments and groundbreaking discoveries.

Natalie Artzi, PhD and Roger J. Hajjar, MD in lab

GCTI Leadership

Roger J. Hajjar, MD

Head of Institute
Marcela V. Maus, MD, PhD

Associate Head & Head of Cell Therapies
Nathan L. Yozwiak, PhD

Head of Research
Natalie Artzi, PhD

Head of Structural Nanomedicines
Angela Shen, MD, MBA

Head of Regulatory
Dana M. Hammill, MS, MBA

Head of Manufacturing & CMC
Meini S. Shin, MBA

Head of Strategic Planning & Operations
Omar Abudayyeh, PhD

Director of Gene Editing
Robert Alexander Wesselhoeft, PhD

Director of RNA Therapeutics

GCTI Team

Gang Ning, PhD

Manager of RNA Therapeutics and Gene Editing Cores
Nandhitha Uma Naresh, PhD

Program Manager
Isabella M. Zamora, MPH

Manufacturing/Program Coordinator
Susanti Sugianto, MSF

Program Coordinator

Gene and Cell Therapy Institute

Gene and cell therapy research at Mass General Brigham is rapidly advancing, pushing the technological and clinical boundaries of this new frontier. Learn more about how we are revolutionizing patient care.

About us